89 related articles for article (PubMed ID: 6929442)
1. Labetelol as a hypotensive agent compared to other sympatholytic or vasodilator agents.
Oates HF
N Z Med J; 1980 Jan; 91(652):66. PubMed ID: 6929442
[No Abstract] [Full Text] [Related]
2. [Acute hemodynamic effect of labetalol in severe hypertension].
Omvik P; Lund-Johansen P
Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
[No Abstract] [Full Text] [Related]
3. [Ergometric control in hypertension treatment with labetalol].
Prohaska H; Honetz N
Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
[No Abstract] [Full Text] [Related]
4. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
Kristensen BO; la Cour Petersen E
Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344
[No Abstract] [Full Text] [Related]
5. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
[No Abstract] [Full Text] [Related]
6. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
[No Abstract] [Full Text] [Related]
7. Rate of onset of hypotensive effect of oral labetalol.
Serlin MJ; Orme MC; Maciver M; Green GJ; Macnee CM; Breckenridge AM
Br J Clin Pharmacol; 1979 Feb; 7(2):165-8. PubMed ID: 760748
[TBL] [Abstract][Full Text] [Related]
8. Minoxidil and labetalol: very effective antihypertensive combination.
Whiting G; Craswell P; Boyle P; Bett N
Med J Aust; 1980 Mar; 1(5):225-6. PubMed ID: 7374568
[TBL] [Abstract][Full Text] [Related]
9. Poor hypotensive response and tachyphylaxis following intravenous labetalol.
Anderson CC; Gabriel R
Curr Med Res Opin; 1978; 5(5):424-6. PubMed ID: 350494
[TBL] [Abstract][Full Text] [Related]
10. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
Gyimesi A; Hanyecz V; Pocsay G; Iványi J
Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
[No Abstract] [Full Text] [Related]
11. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
la Cour Petersen E; Kristensen BO
Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
[TBL] [Abstract][Full Text] [Related]
12. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
[TBL] [Abstract][Full Text] [Related]
13. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertension by labetalol (author's transl)].
Sternon J; Melot C; Contu E
Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
[No Abstract] [Full Text] [Related]
15. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
Vas A; Gachályi B; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
[No Abstract] [Full Text] [Related]
16. [Labetalol in resistant hypertension].
Stern N; Teicher A; Rosenthal T
Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
[No Abstract] [Full Text] [Related]
17. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
[No Abstract] [Full Text] [Related]
18. Hemodynamic long-term effects of labetalol in essential hypertension.
Lund-Johansen P
Acta Med Scand Suppl; 1979; 625():54-8. PubMed ID: 285576
[No Abstract] [Full Text] [Related]
19. [Labetalol in the treatment of resistant hypertension].
Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
[No Abstract] [Full Text] [Related]
20. Proceedings of the Third Symposium on Labetalol.
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):1S-141S. PubMed ID: 7093091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
